DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar p1a5244 (64.20) Submitted: 9/11/2011 7:12:48 PM : Outperform Start Price: $1.46 DRRX Score: -51.93

Options Predictor Rank #48 on 9/11/11. P/C Ratio 0.186 and Call Sizzle 3.817.

Featured Broker Partners


Advertisement